Lexicon Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US5288723027

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Lonnel Coats. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Se højest rangerende insidere
Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Lonnel Coats har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:BPMC / Blueprint Medicines Corporation Director 0
US:LXRX / Lexicon Pharmaceuticals, Inc. Chief Executive Officer, Director 1.098.068
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Lonnel Coats. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb LXRX / Lexicon Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LXRX / Lexicon Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Maks		 Pris kl
Maks		 Maks
Fortjeneste ($)		 Maks. afkast (%)
2023-11-16 LXRX COATS LONNEL 90.000 1,0533 90.000 1,0533 94.797 91 3.5800 227.403 239,88
2023-11-10 LXRX COATS LONNEL 10.000 1,0100 10.000 1,0100 10.100
2023-06-29 LXRX COATS LONNEL 10.000 2,1600 10.000 2,1600 21.600
2023-06-26 LXRX COATS LONNEL 10.000 2,1792 10.000 2,1792 21.792
2023-06-23 LXRX COATS LONNEL 10.000 2,4950 10.000 2,4950 24.950
2023-06-22 LXRX COATS LONNEL 40.000 2,3100 40.000 2,3100 92.400
2019-09-18 LXRX COATS LONNEL 50.000 3,1000 50.000 3,1000 155.000
2019-09-17 LXRX COATS LONNEL 100 3,1250 100 3,1250 312
2019-09-17 LXRX COATS LONNEL 3.000 3,1190 3.000 3,1190 9.357
2019-09-17 LXRX COATS LONNEL 6.333 3,1200 6.333 3,1200 19.759
2019-09-17 LXRX COATS LONNEL 277 3,1296 277 3,1296 867
2019-09-17 LXRX COATS LONNEL 40.290 3,1300 40.290 3,1300 126.108
2019-08-19 LXRX COATS LONNEL 3.000 1,3980 3.000 1,3980 4.194
2019-08-16 LXRX COATS LONNEL 156 1,3250 156 1,3250 207
2019-08-16 LXRX COATS LONNEL 10.044 1,3300 10.044 1,3300 13.359
2019-08-16 LXRX COATS LONNEL 100 1,3350 100 1,3350 134
2019-08-16 LXRX COATS LONNEL 6.600 1,3400 6.600 1,3400 8.844
2019-08-16 LXRX COATS LONNEL 600 1,3450 600 1,3450 807
2019-08-16 LXRX COATS LONNEL 3.500 1,3500 3.500 1,3500 4.725
2019-08-16 LXRX COATS LONNEL 16.000 1,3600 16.000 1,3600 21.760
2017-11-15 LXRX COATS LONNEL 10.000 9,9100 10.000 9,9100 99.100
2017-09-15 LXRX COATS LONNEL 300 12,4866 300 12,4866 3.746
2017-09-15 LXRX COATS LONNEL 300 12,4850 300 12,4850 3.746
2017-09-15 LXRX COATS LONNEL 3.300 12,5200 3.300 12,5200 41.316
2017-09-15 LXRX COATS LONNEL 5.200 12,5400 5.200 12,5400 65.208
2017-09-15 LXRX COATS LONNEL 3.247 12,5366 3.247 12,5366 40.706
2017-09-15 LXRX COATS LONNEL 4.253 12,5300 4.253 12,5300 53.290
2017-09-15 LXRX COATS LONNEL 400 12,5350 400 12,5350 5.014
2017-09-15 LXRX COATS LONNEL 2.400 12,5500 2.400 12,5500 30.120
2017-09-15 LXRX COATS LONNEL 1.951 12,5600 1.951 12,5600 24.505
2017-09-15 LXRX COATS LONNEL 2.000 12,5700 2.000 12,5700 25.140
2017-09-15 LXRX COATS LONNEL 600 12,5166 600 12,5166 7.510
2017-09-15 LXRX COATS LONNEL 300 12,5498 300 12,5498 3.765
2017-09-15 LXRX COATS LONNEL 1.200 12,5766 1.200 12,5766 15.092
2017-09-15 LXRX COATS LONNEL 149 12,5662 149 12,5662 1.872
2017-09-15 LXRX COATS LONNEL 194 12,5100 194 12,5100 2.427
2017-09-15 LXRX COATS LONNEL 400 12,5162 400 12,5162 5.006
2017-09-15 LXRX COATS LONNEL 100 12,5150 100 12,5150 1.252
2017-09-15 LXRX COATS LONNEL 1.200 12,5190 1.200 12,5190 15.023
2017-09-15 LXRX COATS LONNEL 306 12,5370 306 12,5370 3.836
2017-09-15 LXRX COATS LONNEL 300 12,5761 300 12,5761 3.773
2017-09-15 LXRX COATS LONNEL 300 12,6466 300 12,6466 3.794
2017-09-15 LXRX COATS LONNEL 600 12,6166 600 12,6166 7.570
2017-09-15 LXRX COATS LONNEL 300 12,6161 300 12,6161 3.785
2017-09-15 LXRX COATS LONNEL 300 12,6232 300 12,6232 3.787
2017-09-15 LXRX COATS LONNEL 400 12,6361 400 12,6361 5.054

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Insidersalg LXRX / Lexicon Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LXRX / Lexicon Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Min		 Pris kl
Min		 Max tab
Undgået ($)		 Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Lonnel Coats som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om		 Del
Pris		 Tran
Værdi		 Tilbage
Værdi
2025-07-21 2025-07-17 4 BPMC Blueprint Medicines Corp
Common Stock 		D - Sale to Issuer -6.144 0 -100,00
2025-06-24 2025-06-18 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 3.902 6.144 174,04 12.812,00 49.992.424 78.716.928
2024-11-22 2024-11-21 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -9.824 2.242 -81,42 94,87 -932.003 212.699
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -213 12.066 -1,73 94,99 -20.233 1.146.149
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -5.287 12.279 -30,10 94,24 -498.247 1.157.173
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -4.500 17.566 -20,39 93,15 -419.175 1.636.273
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise X 1.312 22.066 6,32 76,24 100.027 1.682.312
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise X 7.500 20.754 56,59 69,79 523.425 1.448.422
2024-06-14 2024-06-12 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2.242 13.254 20,36
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -61.371 1.098.068 -5,29 2,62 -160.792 2.876.938
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 120.383 1.159.439 11,59
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 91.364 1.039.056 9,64
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33.333 947.692 3,65
2023-11-17 2023-11-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 90.000 914.359 10,92 1,05 94.797 963.094
2023-11-13 2023-11-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10.000 824.359 1,23 1,01 10.100 832.603
2023-06-29 2023-06-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10.000 814.359 1,24 2,16 21.600 1.759.015
2023-06-26 2023-06-26 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10.000 804.359 1,26 2,18 21.792 1.752.859
2023-06-26 2023-06-23 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10.000 794.359 1,27 2,50 24.950 1.981.926
2023-06-23 2023-06-21 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2.600 11.012 30,91
2023-06-22 2023-06-22 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 40.000 784.359 5,37 2,31 92.400 1.811.869
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -50.971 744.359 -6,41 2,17 -110.607 1.615.259
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 91.363 795.330 12,98
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33.334 703.967 4,97
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 84.630 670.633 14,44
2022-06-30 2022-06-21 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2.600 8.412 44,74
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -33.333 66.667 -33,33
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -84.630 84.630 -50,00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -79.380 0 -100,00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -48.053 586.003 -7,58 2,85 -136.951 1.670.109
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33.333 634.056 5,55
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 84.630 600.723 16,40
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 79.380 516.093 18,18
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 274.090 274.090
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 822.280 822.280
2021-06-04 2021-06-02 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 4.500 4.500
2021-06-04 2021-06-02 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2.250 5.812 63,17
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -84.630 169.260 -33,33
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -79.380 79.380 -50,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -23.513 0 -100,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5.362 0 -100,00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -55.038 436.713 -11,19 7,19 -395.723 3.139.966
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 84.630 491.751 20,79
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 79.380 407.121 24,22
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23.513 327.741 7,73
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5.362 304.228 1,79
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 300.000 300.000
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 100.000 100.000
2020-06-26 2020-06-24 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 4.500 4.500
2020-06-26 2020-06-24 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2.250 3.562 171,49
2020-06-23 2020-06-19 4 BPMC Blueprint Medicines Corp
Restricted Stock Units 		M - Exercise -1.312 0 -100,00
2020-06-23 2020-06-19 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise 1.312 1.312
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -79.380 158.760 -33,33
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -23.514 23.513 -50,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5.363 5.362 -50,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -8.390 0 -100,00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -45.320 298.866 -13,17 2,77 -125.536 827.859
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 79.380 344.186 29,98
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23.514 264.806 9,75
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5.363 241.292 2,27
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8.390 235.929 3,69
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 761.660 761.660
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 253.890 253.890
2019-09-19 2019-09-18 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 50.000 227.539 28,16 3,10 155.000 705.371
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 40.290 177.539 29,36 3,13 126.108 555.697
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 277 137.249 0,20 3,13 867 429.534
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 6.333 136.972 4,85 3,12 19.759 427.353
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3.000 130.639 2,35 3,12 9.357 407.463
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 100 127.639 0,08 3,12 312 398.872
2019-08-20 2019-08-19 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3.000 127.539 2,41 1,40 4.194 178.300
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 16.000 124.539 14,74 1,36 21.760 169.373
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3.500 108.539 3,33 1,35 4.725 146.528
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 600 105.039 0,57 1,34 807 141.277
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 6.600 104.439 6,75 1,34 8.844 139.948
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 100 97.839 0,10 1,34 134 130.615
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10.044 97.739 11,45 1,33 13.359 129.993
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 156 87.695 0,18 1,32 207 116.196
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		M - Exercise -10.000 11.818 -45,83
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -4.200 0 -100,00 81,59 -342.678
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -3.098 4.200 -42,45 82,48 -255.523 346.416
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -2.702 7.298 -27,02 83,57 -225.806 609.894
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise 10.000 10.000 15,01 150.100 150.100
2019-06-20 2019-06-19 4 BPMC Blueprint Medicines Corp
Restricted Stock Units 		A - Award 1.312 1.312
2019-06-20 2019-06-19 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 4.875 4.875
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -23.513 47.027 -33,33
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5.363 10.725 -33,34
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -8.390 8.390 -50,00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -10.835 0 -100,00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -18.641 87.539 -17,56 5,51 -102.712 482.340
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23.513 106.180 28,44
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5.363 82.667 6,94
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8.390 77.304 12,17
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10.835 68.914 18,66
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 238.140 238.140
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 442.260 442.260
2018-06-25 2018-06-21 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 7.500 51.136 17,19
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5.362 16.088 -25,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -8.390 16.780 -33,33
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -10.836 10.835 -50,00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -9.494 58.079 -14,05 8,53 -80.984 495.414
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5.362 67.573 8,62
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8.390 62.211 15,59
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10.836 53.821 25,21
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 211.610 211.610
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 70.540 70.540
2017-11-15 2017-11-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10.000 42.985 30,32 9,91 99.100 425.981
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 400 32.985 1,23 12,64 5.054 416.802
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 32.585 0,93 12,62 3.787 411.327
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 32.285 0,94 12,62 3.785 407.311
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 600 31.985 1,91 12,62 7.570 403.542
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 31.385 0,97 12,65 3.794 396.914
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 31.085 0,97 12,58 3.773 390.928
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 306 30.785 1,00 12,54 3.836 385.952
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 1.200 30.479 4,10 12,52 15.023 381.567
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 100 29.279 0,34 12,52 1.252 366.427
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 400 29.179 1,39 12,52 5.006 365.210
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 194 28.779 0,68 12,51 2.427 360.025
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 149 28.585 0,52 12,57 1.872 359.205
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 1.200 28.436 4,41 12,58 15.092 357.628
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 27.236 1,11 12,55 3.765 341.806
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 600 26.936 2,28 12,52 7.510 337.147
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 2.000 26.336 8,22 12,57 25.140 331.044
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 1.951 24.336 8,72 12,56 24.505 305.660
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 2.400 22.385 12,01 12,55 30.120 280.932
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 400 19.985 2,04 12,54 5.014 250.512
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 4.253 19.585 27,74 12,53 53.290 245.400
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3.247 15.332 26,87 12,54 40.706 192.211
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 5.200 12.085 75,53 12,54 65.208 151.546
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3.300 6.885 92,05 12,52 41.316 86.200
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 3.585 9,13 12,48 3.746 44.759
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 3.285 10,05 12,49 3.746 41.018
2017-06-23 2017-06-21 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 10.909 43.636 33,33
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		M - Exercise -8.390 25.170 -25,00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		M - Exercise -10.836 21.671 -33,33
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -5.258 20.767 -20,20 16,45 -86.494 341.617
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8.390 26.025 47,58
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10.836 17.635 159,38
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		A - Award 21.450 21.450
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 85.780 85.780
2016-06-27 2016-06-23 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 10.909 32.727 50,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		M - Exercise -10.835 32.507 -25,00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -4.036 6.799 -37,25 9,07 -36.607 61.667
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10.835 10.835
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		A - Award 33.560 33.560
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 134.230 134.230
2016-02-05 2016-02-03 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 21.818 21.818
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 1.213.600 1.213.600
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		A - Award 303.400 303.400
2014-07-08 2014-07-07 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy) 		A - Award 853.500 853.500
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)